Ocugen, Inc.
DE ˙ DB ˙ US67577C1053
1,15 € ↑0,02 (2,13%)
2026-06-05
DEL PRIS
SecurityDE:2H51 / Ocugen, Inc.
InstitutionGeode Capital Management, Llc
Latest Disclosed Ownership4,227,104 shares
Latest Disclosed Value $ 7,654,796
Geode Capital Management, Llc reports 10.68% increase in ownership of 2H51 / Ocugen, Inc.

On May 15, 2026 - Geode Capital Management, Llc filed a 13F-HR form disclosing ownership of 4,227,104 shares of Ocugen, Inc. (DE:2H51) valued at $6,623,872 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 3,819,242 shares of Ocugen, Inc.. This represents a change in shares of 10.68% during the quarter. The current value of the position is $4,861,170 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F OCUGEN COM 67577C105 4,227,104 407,862 10.68 7,655 48.39 0.0003
2026-02-09 2025-12-31 13F OCUGEN COM 67577C105 3,819,242 142,050 3.86 5,159 -13.96 0.0003
2025-11-12 2025-09-30 13F OCUGEN COM 67577C105 3,677,192 189,391 5.43 5,996 77.10 0.0004
2025-08-08 2025-06-30 13F OCUGEN COM 67577C105 3,487,801 -3,401,020 -49.37 3,386 -30.44 0.0002
2025-05-13 2025-03-31 13F OCUGEN COM 67577C105 6,888,821 300,414 4.56 4,867 -8.26 0.0004
2025-02-12 2024-12-31 13F OCUGEN COM 67577C105 6,588,407 309,853 4.94 5,305 -14.86 0.0004
2024-11-12 2024-09-30 13F OCUGEN COM 67577C105 6,278,554 373,555 6.33 6,231 -31.94 0.0005
2024-08-09 2024-06-30 13F OCUGEN COM 67577C105 5,904,999 2,691,479 83.75 9,155 73.67 0.0008
2024-05-13 2024-03-31 13F OCUGEN COM 67577C105 3,213,520 283,572 9.68 5,271 212.82 0.0005
2024-02-13 2023-12-31 13F OCUGEN COM 67577C105 2,929,948 68,485 2.39 1,685 47.29 0.0002
2023-11-13 2023-09-30 13F OCUGEN COM 67577C105 2,861,463 -1,505 -0.05 1,145 -26.38 0.0001
2023-08-11 2023-06-30 13F OCUGEN COM 67577C105 2,862,968 -1,798,365 -38.58 1,555 -60.92 0.0002
2023-05-15 2023-03-31 13F OCUGEN COM 67577C105 4,661,333 517,806 12.50 3,977 79,420.00 0.0005
2023-02-13 2022-12-31 13F OCUGEN COM 67577C105 4,143,527 337,579 8.87 5 -99.93 0.0008
2022-11-14 2022-09-30 13F OCUGEN COM 67577C105 3,805,948 126,842 3.45 6,774 -18.88 0.0010
2022-08-12 2022-06-30 13F OCUGEN COM 67577C105 3,679,106 835,005 29.36 8,351 -11.02 0.0012
2022-05-13 2022-03-31 13F OCUGEN COM 67577C105 2,844,101 -430,234 -13.14 9,385 -37.00 0.0012
2022-02-11 2021-12-31 13F OCUGEN COM 67577C105 3,274,335 -82,481 -2.46 14,898 -38.19 0.0018
2021-11-12 2021-09-30 13F OCUGEN COM 67577C105 3,356,816 173,982 5.47 24,101 -5.70 0.0032
2021-08-13 2021-06-30 13F OCUGEN COM 67577C105 3,182,834 1,547,662 94.65 25,558 130.21 0.0035
2021-05-12 2021-03-31 13F OCUGEN COM 67577C105 1,635,172 418,757 34.43 11,102 398.74 0.0017
2021-02-12 2020-12-31 13F OCUGEN COM 67577C105 1,216,415 671,075 123.06 2,226 1,217.16 0.0004
2020-11-13 2020-09-30 13F OCUGEN COM 67577C105 545,340 344,757 171.88 169 284.09 0.0000
2020-08-13 2020-06-30 13F OCUGEN COM 67577C105 200,583 0 0.00 44 -21.43 0.0000
2020-05-14 2020-03-31 13F OCUGEN COM 67577C105 200,583 -151,101 -42.96 56 -16.42 0.0000
2019-08-14 2019-06-30 13F HISTOGENICS COM 43358V109 351,684 59,941 20.55 67 103.03 0.0000
2019-05-14 2019-03-31 13F HISTOGENICS COM 43358V109 291,743 0 0.00 33 32.00 0.0000
2019-03-06 2018-12-31 13F/A-1 HISTOGENICS COM 43358V109 291,743 291,743 25 0.0000
2019-02-13 2018-12-31 13F HISTOGENICS COM 43358V109 291,743 25 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.